Alliancebernstein L.P. Trevena Inc Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $4,240 - $10,600	-21,200 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.41 - $0.63 $41 - $63	100 Added 0.47%	21,200 $12,000
Q2 2021 Jul 30, 2021	BUY	$1.46 - $2.25 $30,806 - $47,475	21,100 New	21,100 $36,000
Q2 2018 Aug 13, 2018	SELL	$1.44 - $2.24 $65,376 - $101,696	-45,400 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$1.4 - $2.6 $13,860 - $25,740	-9,900 Reduced 17.9%	45,400 $73,000
Q3 2017 Nov 13, 2017	BUY	$2.22 - $2.79 $122,766 - $154,287	55,300	55,300 $141,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.